Accuracy of clinical diagnosis of dementia with Lewy bodies: a systematic review and meta-analysis

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of Neurology Neurosurgery & Psychiatry

• Publication date

  2017-10-13

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/jnnp-2017-316844PMID 29030419
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Editors' note: A new potential biomarker for dementia with Lewy bodies: Skin nerve α-synuclein deposits

  2018cited by this paper
• Reader response: Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB consortium

  2018cited by this paper
• A new potential biomarker for dementia with Lewy bodies

  2017cited by this paper
• Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis.

  2017cited by this paper
• Diagnosis and management of dementia with Lewy bodies

  2017cited by this paper
• Accuracy of clinical diagnosis of Parkinson disease

  2016cited by this paper
• Prevalence of Submandibular Gland Synucleinopathy in Parkinson’s Disease, Dementia with Lewy Bodies and other Lewy Body Disorders

  2016cited by this paper
• Accuracy of clinical diagnosis of Parkinson disease: A systematic review and meta-analysis

  2016cited by this paper
• Abolishing the 1‐year rule: How much evidence will be enough?

  2016cited by this paper
• Arguing against the proposed definition changes of PD

  2016cited by this paper
• Association between cerebral small vessel diseases and mild parkinsonian signs in the elderly with vascular risk factors.

  2016cited by this paper
• 123I‐2β‐carbomethoxy‐3β‐(4‐iodophenyl)‐N‐(3‐fluoropropyl) nortropane single photon emission computed tomography and 123I‐metaiodobenzylguanidine myocardial scintigraphy in differentiating dementia with lewy bodies from other dementias: A comparative study

  2016cited by this paper
• When DLB, PD, and PSP masquerade as MSA

  2015cited by this paper
• Clinicians' ability to diagnose dementia with Lewy bodies is not affected by β-amyloid load

  2015cited by this paper
• Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer's Coordinating Centre.

  2013cited by this paper
• Incidence of dementia with Lewy bodies and Parkinson disease dementia.

  2013cited by this paper
• Co-occurrence of Different Pathologies in Dementia: Implications for Dementia Diagnosis

  2012cited by this paper
• Diagnostic Performance of Myocardial Innervation Imaging Using MIBG Scintigraphy in Differential Diagnosis between Dementia with Lewy Bodies and Other Dementias: A Systematic Review and a Meta‐Analysis

  2012cited by this paper
• Inclusion of RBD improves the diagnostic classification of dementia with Lewy bodies

  2011cited by this paper
• Low sensitivity in clinical diagnoses of dementia with Lewy bodies

  2010cited by this paper
• Dopamine transporter single photon emission computerized tomography in the diagnosis of dementia with Lewy bodies

  2009cited by this paper
• Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement

  2009cited by this paper
• Medial temporal lobe atrophy on MRI differentiates Alzheimer's disease from dementia with Lewy bodies and vascular cognitive impairment: a prospective study with pathological verification of diagnosis.

  2009cited by this paper
• Rapidly progressive neurodegenerative dementias.

  2009cited by this paper
• Validation of the Neuropathologic Criteria of the Third Consortium for Dementia With Lewy Bodies for Prospectively Diagnosed Cases

  2008cited by this paper
• BEATING A DEAD HORSE: DOPAMINE AND PARKINSON DISEASE

  2008cited by this paper
• In dementia with Lewy bodies, Braak stage determines phenotype, not Lewy body distribution

  2007cited by this paper
• Diagnosis and management of dementia with Lewy bodies

  2005cited by this paper
• Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium

  2005cited by this paper
• Consensus Statement

  2004cited by this paper
• Accuracy of diagnosis in dementia with Lewy bodies.

  2003cited by this paper
• Neuropathologic changes in Parkinson disease with late onset of dementia.

  2003cited by this paper
• Research evaluation and prospective diagnosis of dementia with Lewy bodies.

  2002cited by this paper
• Neuropathological correlates to clinically defined dementia with Lewy bodies

  2001cited by this paper
• Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group.

  2000cited by this paper
• Prospective validation of Consensus criteria for the diagnosis of dementia with Lewy bodies

  2000cited by this paper
• Diagnostic accuracy of dementia with Lewy bodies.

  2000cited by this paper
• Validity of current clinical criteria for Alzheimer's disease, vascular dementia and dementia with Lewy bodies

  1999cited by this paper
• Accuracy of four clinical diagnostic criteria for the diagnosis of neurodegenerative dementias

  1999cited by this paper
• Sensitivity and specificity of three clinical criteria for dementia with Lewy bodies in an autopsy‐verified sample

  1999cited by this paper
• Lewy body disease: can we diagnose it?

  1998cited by this paper
• Accuracy of the clinical diagnoses of Lewy body disease, Parkinson disease, and dementia with Lewy bodies: a clinicopathologic study.

  1998cited by this paper
• Dementia with Lewy bodies

  1996cited by this paper
• Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB)

  1996cited by this paper
• The Clinical Diagnosis and Misdiagnosis of Senile Dementia of Lewy Body Type (SDLT)

  1994cited by this paper
• An evaluation of the predictive validity and inter‐rater reliability of clinical diagnostic criteria for senile dementia of Lewy body type

  1994cited by this paper
• The Lewy-Body Variant of Alzheimer's Disease

  1993cited by this paper
• Operational criteria for senile dementia of Lewy body type (SDLT)

  1992cited by this paper
• Dementia associated with cortical Lewy bodies : proposed clinical diagnostic criteria

  1991cited by this paper
• Diffuse type of Lewy body disease: progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree--a new disease?

  1984cited by this paper
• DIFFUSE INTRACYTOPLASMIC GANGLIONIC INCLUSIONS (LEWY TYPE) ASSOCIATED WITH PROGRESSIVE DEMENTIA AND QUADRIPARESIS IN FLEXION

  1961cited by this paper

• Graphic transmutations identify the phenomenon of meaningless pictures remembered as familiar objects

  2026cites this paper
• α-Synuclein seed amplification assay methodology and performance in Parkinson's disease, lewy body dementia, and multiple system atrophy: A meta-analysis.

  2026cites this paper
• Imaging brain class I histone deacetylase changes in the Lewy body dementias and Parkinson’s disease

  2026cites this paper
• Accuracy of clinical diagnosis in neurodegenerative diseases - a study of 455 autopsy cases

  2026cites this paper
• Sensitive Detection of DJ-1 in Artificial Cerebrospinal Fluid Using a Portable GPTMS-Coordinated Gold Nanoparticle-Based Biosensor

  2026cites this paper
• Rapid Eye Movement Sleep Behavior Disorder with Clinical Dementia with Lewy Bodies Phenotype but Lacking Postmortem Central Nervous System Synuclein Pathology: Alternate Etiologies.

  2026cites this paper
• Neuropathology of Lewy body dementia: Lewy-related pathology, α-synuclein oligomers, and comorbid pathologies

  2025cites this paper
• Marcatori biologici delle malattie neurodegenerative

  2025cites this paper
• APOE ε4 linked effects on clinical features and neuropathology in dementia with Lewy bodies

  2025cites this paper
• Genome-wide association study provides insights into the genetic basis of Lewy body dementia

  2025cites this paper
• Differential diagnosis of dementias using in vivo MRI and data-driven disease progression modelling: a case study in Alzheimer's disease and dementia with Lewy bodies

  2025cites this paper
• Heterogeneity of dementia with Lewy bodies: Insights from clinical presentations, neuropathology, and biomarkers

  2025cites this paper
• Metabolic brain networks in dementia with Lewy bodies: from prodromal to manifest disease stages

  2025cites this paper
• Safety and efficacy of pimavanserin in patients with Lewy body dementia experiencing dementia-related psychosis in the HARMONY study

  2025cites this paper
• α‐Synuclein seed amplification assay in Lewy body dementia versus Alzheimer's disease

  2025cites this paper
• Digital neuropathology of neurodegenerative disorders: Foundations, research advances, and future directions

  2025cites this paper
• The association between plasma and MRI biomarkers in dementia with lewy bodies

  2025cites this paper
• Imaging brain class I histone deacetylase changes in the Lewy body dementias and Parkinson’s disease

  2025cites this paper
• Lewy body dementia: exploring biomarkers and pathogenic interactions of amyloid β, tau, and α-synuclein

  2025cites this paper
• Postmortem Validation of Quantitative MRI for White Matter Hyperintensities in Alzheimer's Disease

  2025cites this paper
• It is time to share Alzheimer biomarker results in dementia with Lewy bodies

  2025cites this paper
• Quantitative electroencephalography in the diagnosis of dementia with Lewy bodies

  2025cites this paper
• Benchmarking the AI-based diagnostic potential of plasma proteomics for neurodegenerative disease in 17,170 people

  2025cites this paper
• Multiplex Proteomics of Lewy Body Dementia Reveals Cerebrospinal Fluid Biomarkers of Disease Pathology and Progression

  2025cites this paper
• Marqueurs biologiques des maladies neurodégénératives

  2025cites this paper
• Accurate detection of pathologic α-synuclein in CSF, skin, olfactory mucosa, and urine with a uniform seeding amplification assay

  2025cites this paper
• Sex differences in prodromal dementia with Lewy bodies using the National Alzheimer's Coordinating Center data

  2025cites this paper
• Examining the lived experience of dementia with Lewy bodies through qualitative research: A systematic review

  2025cites this paper
• Biomaterials and Tissue Engineering Strategies for Management of Neurodegeneration: A Critical Perspective

  2025cites this paper
• α-synuclein and tau: interactions, cross-seeding, and the redefinition of synucleinopathies as complex proteinopathies

  2025cites this paper
• Mitochondrial Dysfunction in Neurodegenerative Diseases

  2025cites this paper
• Sex differences for regional pathology in people with a high likelihood of Lewy body dementia phenotype based on underlying pathology

  2025cites this paper
• Identifying gait differences between Alzheimer's disease and dementia with Lewy bodies and their associations with regional amyloid deposition

  2025cites this paper
• Toward alpha‐synuclein seed amplification assay in clinical practice

  2025cites this paper
• Recent progresses in natural based therapeutic materials for Alzheimer's disease

  2024cites this paper
• Differentiating anti-IgLON5 disease and Lewy body dementia: a systematic review

  2024cites this paper
• From onset to advancement: the temporal spectrum of α-synuclein in synucleinopathies.

  2024cites this paper
• Corticotropin-releasing hormone as a candidate biomarker for parkinsonian disorders

  2024cites this paper
• Performance of plasma p‐tau217 and NfL in an unselected memory clinic setting

  2024cites this paper
• Sensitivity and specificity of a seed amplification assay for diagnosis of multiple system atrophy: a multicentre cohort study.

  2024cites this paper
• Neurofilament heavy phosphorylated epitopes as biomarkers in ageing and neurodegenerative disease

  2024cites this paper
• Daily Life Experiences of People with Dementia with Lewy Bodies: A Qualitative Study

  2024cites this paper
• EEG Functional Connectivity Differences Predict Future Conversion to Dementia in Mild Cognitive Impairment With Lewy Body or Alzheimer Disease

  2024cites this paper
• The association between cigarette smoking and dementia with Lewy bodies.

  2024cites this paper
• Neuropsychological and neuroanatomical underpinnings of the face pareidolia errors on the noise pareidolia test in patients with mild cognitive impairment and dementia due to Lewy bodies

  2024cites this paper
• Aptamer binding footprints discriminate α-synuclein fibrillar polymorphs from different synucleinopathies

  2024cites this paper
• Differences in trajectories of quality of life according to type of dementia: 6-year longitudinal findings from the IDEAL programme

  2024cites this paper
• Novel Blood-Based Biomarkers and Disease Modifying Therapies for Alzheimer's Disease. Are We Ready for the New Era?

  2024cites this paper
• Practical use of DAT SPECT imaging in diagnosing dementia with Lewy bodies: a US perspective of current guidelines and future directions

  2024cites this paper
• Visual processing speed and its association with future dementia development in a population-based prospective cohort: EPIC-Norfolk

  2024cites this paper
• Deep learning reveals pathology-confirmed neuroimaging signatures in Alzheimer’s, vascular and Lewy body dementias

  2024cites this paper
• Validation of the Turkish version of the Lewy body composite risk score

  2023cites this paper
• Costs During the Last Five Years of Life for Patients with Clinical and Pathological Confirmed Diagnosis of Lewy Body Dementia and Alzheimer’s Disease

  2023cites this paper
• Demenz mit Lewy-Körpern: alte und neue Erkenntnisse – Teil 1: Klinik und Diagnostik

  2023cites this paper
• Postmortem Brain Imaging in Alzheimer’s Disease and Related Dementias: The South Texas Alzheimer’s Disease Research Center Repository

  2023cites this paper
• Elucidating distinct molecular signatures of Lewy body dementias.

  2023cites this paper
• APOE-ε4 and BIN1 increase risk of Alzheimer’s disease pathology but not specifically of Lewy body pathology

  2023cites this paper
• Different language profiles on neuropsychological tests in dementia with Lewy bodies and Alzheimer’s disease

  2023cites this paper
• Emerging drugs for dementia with Lewy Bodies: a review of Phase II & III trials

  2023cites this paper
• Case Study 5: A 74-Year-Old Man With Dysphagia, Weakness, and Memory Loss.

  2023cites this paper
• Longitudinal motor decline in dementia with Lewy bodies, Parkinson disease dementia, and Alzheimer's dementia in a community autopsy cohort

  2023cites this paper
• Depression in dementia with Lewy bodies: a critical update

  2023cites this paper
• Clinical trials in dementia with Lewy bodies: the evolving concept of co-pathologies, patient selection and biomarkers

  2023cites this paper
• [The clinical value of 123I-metaiodobenzylguanidine myocardial imaging in the diagnosis of dementia with Lewy bodies].

  2023cites this paper
• Race and Ethnicity in Lewy Body Dementia: A Narrative Review

  2023cites this paper
• Clinical validation of the cingulate island sign visual rating scale in dementia with Lewy bodies.

  2023cites this paper
• Morphological characteristics differentiate dementia with Lewy bodies from Parkinson disease with and without dementia

  2023cites this paper
• Ecological validity of cognitive fluctuations in dementia with Lewy bodies

  2023cites this paper
• Dispersion-based cognitive intra-individual variability in dementia with Lewy bodies.

  2022cites this paper
• Lewy body disease or diseases with Lewy bodies?

  2022cites this paper
• Validation of the National Alzheimer's Coordinating Center (NACC) Lewy Body Disease Module neuropsychological tests

  2022influential citation
• Autopsy Validation of the Diagnostic Accuracy of 123I-Metaiodobenzylguanidine Myocardial Scintigraphy for Lewy Body Disease

  2022cites this paper
• Fluid Biomarkers in Alzheimer’s Disease and Other Neurodegenerative Disorders: Toward Integrative Diagnostic Frameworks and Tailored Treatments

  2022cites this paper
• Potential Protein Blood-Based Biomarkers in Different Types of Dementia: A Therapeutic Overview.

  2022cites this paper
• Distinguishing Lewy Body Dementia from Alzheimer's Disease using Machine Learning on Heterogeneous Data: A Feasibility Study

  2022cites this paper
• Are there morphological differences between Parkinson's disease-dementia and dementia with Lewy bodies?

  2022cites this paper
• Metabolic brain pattern in dementia with Lewy bodies: Relationship to Alzheimer’s disease topography

  2022cites this paper
• Biomarkers of Dementia with Lewy Bodies: Differential Diagnostic with Alzheimer’s Disease

  2022cites this paper
• The Alzheimer's Association appropriate use recommendations for blood biomarkers in Alzheimer's disease

  2022influential citation
• A Review of Application of Aβ42/40 Ratio in Diagnosis and Prognosis of Alzheimer’s Disease

  2022cites this paper
• Metric magnetic resonance imaging analysis reveals pronounced substantia-innominata atrophy in dementia with Lewy bodies with a psychiatric onset

  2022cites this paper
• Management of Psychiatric Phenomena in Lewy Body Dementia

  2022cites this paper
• "The Use of Proteomics in Dementia with Lewy Bodies"/ "From Protein Biomarkers to Proteomics in Dementia with Lewy Bodies".

  2022cites this paper
• Psychometric properties of the Autonomic Symptoms Checklist in the Lewy body disease module of the uniform dataset

  2022cites this paper
• Identification of a sex-specific genetic signature in dementia with Lewy bodies: a meta-analysis of genome-wide association studies

  2022cites this paper
• Blood Biomarkers for the Diagnosis of Neurodegenerative Dementia: A Systematic Review

  2022cites this paper
• From Medical Biochemistry and Biophysics Karolinska Institutet, Stockholm, Sweden

  2022influential citation
• Emerging polymeric biomaterials and manufacturing-based tissue engineering approaches for neuro regeneration-A critical review on recent effective approaches

  2022cites this paper
• Functional brain networks in the evaluation of patients with neurodegenerative disorders

  2022cites this paper
• Design and application of a customizable relational DataBase to assess clinicopathological correlations and concomitant pathology in neurodegenerative diseases

  2022cites this paper
• Sex differences for phenotype in pathologically defined dementia with Lewy bodies

  2021cites this paper
• Plasma and cerebrospinal fluid ABeta42 for the differential diagnosis of Alzheimer's disease dementia in participants diagnosed with any dementia subtype in a specialist care setting.

  2021cites this paper
• Spatial covariance analysis of FDG-PET and HMPAO-SPECT for the differential diagnosis of dementia with Lewy bodies and Alzheimer's disease.

  2021cites this paper
• Identification of a Qualitative Signature for the Diagnosis of Dementia With Lewy Bodies

  2021cites this paper
• The temporal onset of the core features in dementia with Lewy bodies

  2021cites this paper
• Ultrabrief Right Unilateral Electroconvulsive Therapy for the Treatment of the Neuropsychiatric Symptoms of Dementia with Lewy Bodies

  2021cites this paper
• Atypical parkinsonism, parkinsonism-plus syndromes and secondary parkinsonian disorders

  2021cites this paper
• Das Spektrum der atypischen Parkinson-Syndrome im klinischen Alltag

  2021cites this paper
• Added value of semiquantitative analysis of brain FDG-PET for the differentiation between MCI-Lewy bodies and MCI due to Alzheimer’s disease

  2021cites this paper
• Motor Dysfunction Questionnaire and Dopamine Transporter Imaging Composite Scale Improve Differentiating Dementia With Lewy Bodies From Alzheimer's Disease With Motor Dysfunction

  2021cites this paper